Truncating mutations in the terminal exon of PPM1D have been identified in 1.9% of an MPN cohort, and PPM1D was thus the eighth-most mutated gene in myeloproliferative neoplasms. The gene discussed is PPM1D; the disease is myeloproliferative disorder.